Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 1 1 5 28
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 3 19
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 0 9
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 1 6
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 0 0 6 31
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 0 0 29 412
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 47 0 1 6 82
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 1 24
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 16 0 3 16 98
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 0 1 2 6
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 0 0 1 17
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 0 1 6 40
Total Working Papers 0 0 0 63 1 7 76 772


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 2 3 41 0 2 10 149
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 7 0 0 1 31
Total Journal Articles 0 2 3 48 0 2 11 180


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 2 13 1 2 7 76
Total Chapters 0 0 2 13 1 2 7 76


Statistics updated 2022-11-05